Suppression of eIF4E expression by L-Asparaginase.
Suto
Hiroko
H
Department of Internal Medicine, Juntendo University School of Medicine, Tokyo, Japan.
Yasuda
Hajime
H
Isobe
Yasushi
Y
Sasaki
Makoto
M
Imai
Hidenori
H
Tsutsui
Miyuki
M
Oshimi
Kazuo
K
Komatsu
Norio
N
Sugimoto
Koichi
K
D000970:Antineoplastic Agents / Q000494:pharmacology*; D001215:Asparaginase / Q000494:pharmacology*; D002471:Cell Transformation, Neoplastic / Q000378:metabolism*; D039561:Eukaryotic Initiation Factor-4E / Q000096:biosynthesis*; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects*; D006801:Humans; D019169:Jurkat Cells; D009363:Neoplasm Proteins / Q000096:biosynthesis*; D009369:Neoplasms / Q000378:metabolism*
D000970:Antineoplastic Agents; D039561:Eukaryotic Initiation Factor-4E; D009363:Neoplasm Proteins; D001215:Asparaginase